- /
- Supported exchanges /
- NASDAQ /
- SONN.NASDAQ
Sonnet Biotherapeutics Holdings Inc (SONN NASDAQ) stock market data APIs
Sonnet Biotherapeutics Holdings Inc Financial Data Overview
Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 that is in Phase 1b/2a clinical trial for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6, which is in Phase 1b/I2a clinical trail to treat chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy; and SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer. It has a license agreement with New Life Therapeutics Pte, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Sonnet Biotherapeutics Holdings Inc data using free add-ons & libraries
Get Sonnet Biotherapeutics Holdings Inc Fundamental Data
Sonnet Biotherapeutics Holdings Inc Fundamental data includes:
- Net Revenue: 55 881
- EBITDA: -12 263 398
- Earnings Per Share: -11
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-12-12
- EPS/Forecast: -5.52
Get Sonnet Biotherapeutics Holdings Inc End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Sonnet Biotherapeutics Holdings Inc News
7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
Investing in biotech stocks can be challenging. The rewards can be great when your company hits on a popular drug, treatment or product. But there are also plenty of pitfalls that make such investment...
15 Most Volatile Stocks to Buy Now
In this article, we discuss the 15 most volatile stocks to buy now. If you want to read about some more volatile stocks, go directly to 5 Most Volatile Stocks to Buy Now. Even though the United State...
Sonnet BioTherapeutics Shares Jump After Janssen Pact For Its Three Product Candidates
Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN) announced a collaboration agreement with Janssen Biotech Inc, a Johnson & Johnson (NYSE: JNJ) unit. In vitro and in vivo efficacy of SON-1010 (IL12-F...
21 Stocks Moving in Monday's Pre-Market Session
Gainers Valneva SE (NASDAQ: VALN) rose 34.4% to $37.69 in pre-market trading after the company disclosed positive Phase 3 results for inactivated, adjuvanted COVID-19 vaccine candidate VLA2001. Xiaob...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.